End-of-day quote
Shanghai S.E.
03:30:00 10/05/2024 am IST
|
5-day change
|
1st Jan Change
|
40.43
CNY
|
-0.71%
|
|
+5.40%
|
+3.09%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
7,484
|
6,523
|
5,308
|
5,356
|
-
|
-
|
Enterprise Value (EV)
1 |
7,484
|
6,523
|
6,182
|
5,356
|
5,356
|
5,356
|
P/E ratio
|
41.6
x
|
33.5
x
|
23.3
x
|
20.6
x
|
15.9
x
|
14.1
x
|
Yield
|
0.67%
|
-
|
1.91%
|
1.95%
|
2.2%
|
2.82%
|
Capitalization / Revenue
|
13
x
|
9.39
x
|
6.64
x
|
5.4
x
|
4.19
x
|
3.94
x
|
EV / Revenue
|
13
x
|
9.39
x
|
6.64
x
|
5.4
x
|
4.19
x
|
3.94
x
|
EV / EBITDA
|
-
|
27.3
x
|
18.8
x
|
16.3
x
|
12.1
x
|
11.2
x
|
EV / FCF
|
-
|
29.5
x
|
110
x
|
13.6
x
|
28.8
x
|
16.9
x
|
FCF Yield
|
-
|
3.38%
|
0.91%
|
7.36%
|
3.47%
|
5.92%
|
Price to Book
|
8.23
x
|
6.17
x
|
4.16
x
|
3.66
x
|
3.08
x
|
2.66
x
|
Nbr of stocks (in thousands)
|
1,33,333
|
1,33,333
|
1,35,328
|
1,32,483
|
-
|
-
|
Reference price
2 |
56.13
|
48.92
|
39.22
|
40.43
|
40.43
|
40.43
|
Announcement Date
|
24/02/22
|
27/02/23
|
28/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
576.2
|
694.9
|
799.6
|
991.3
|
1,278
|
1,358
|
EBITDA
1 |
-
|
-
|
239.2
|
281.9
|
328
|
442.5
|
480
|
EBIT
1 |
-
|
181.8
|
227.9
|
264.2
|
310.5
|
402.5
|
452.5
|
Operating Margin
|
-
|
31.56%
|
32.79%
|
33.04%
|
31.32%
|
31.51%
|
33.33%
|
Earnings before Tax (EBT)
1 |
-
|
181.8
|
227.5
|
264.2
|
310.5
|
402
|
452.5
|
Net income
1 |
116.5
|
157
|
195.2
|
225.6
|
265
|
344.8
|
387
|
Net margin
|
-
|
27.25%
|
28.09%
|
28.22%
|
26.73%
|
26.99%
|
28.5%
|
EPS
2 |
-
|
1.350
|
1.460
|
1.680
|
1.960
|
2.548
|
2.860
|
Free Cash Flow
1 |
-
|
-
|
220.8
|
48.34
|
394
|
186
|
317
|
FCF margin
|
-
|
-
|
31.77%
|
6.05%
|
39.75%
|
14.56%
|
23.35%
|
FCF Conversion (EBITDA)
|
-
|
-
|
92.28%
|
17.15%
|
120.12%
|
42.03%
|
66.04%
|
FCF Conversion (Net income)
|
-
|
-
|
113.09%
|
21.42%
|
148.68%
|
53.95%
|
81.91%
|
Dividend per Share
2 |
-
|
0.3750
|
-
|
0.7500
|
0.7900
|
0.8900
|
1.140
|
Announcement Date
|
18/05/21
|
24/02/22
|
27/02/23
|
28/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
---|
Net sales
1 |
154.5
|
175.9
|
162.4
|
202
|
EBITDA
|
-
|
-
|
-
|
-
|
EBIT
1 |
54.04
|
61.19
|
51.73
|
60.92
|
Operating Margin
|
34.97%
|
34.79%
|
31.85%
|
30.15%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
26/04/22
|
19/08/22
|
24/10/22
|
27/02/23
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
875
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
3.103
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
221
|
48.3
|
394
|
186
|
317
|
ROE (net income / shareholders' equity)
|
-
|
25.7%
|
19.9%
|
18.8%
|
18.1%
|
19.9%
|
19%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
11.1%
|
7.98%
|
7.5%
|
9.8%
|
9%
|
Assets
1 |
-
|
-
|
1,760
|
2,828
|
3,533
|
3,518
|
4,300
|
Book Value Per Share
2 |
-
|
6.820
|
7.930
|
9.430
|
11.10
|
13.10
|
15.20
|
Cash Flow per Share
2 |
-
|
-
|
2.220
|
1.180
|
2.380
|
2.530
|
2.710
|
Capex
1 |
-
|
-
|
75.6
|
111
|
95
|
67.8
|
67.5
|
Capex / Sales
|
-
|
-
|
10.88%
|
13.85%
|
9.58%
|
5.3%
|
4.97%
|
Announcement Date
|
18/05/21
|
24/02/22
|
27/02/23
|
28/02/24
|
-
|
-
|
-
|
Last Close Price
40.43
CNY Average target price
49.75
CNY Spread / Average Target +23.05% Consensus |
1st Jan change
|
Capi.
|
---|
| +3.09% | 741M | | +17.73% | 66.69B | | +16.33% | 41.24B | | +18.68% | 25.89B | | +12.78% | 19.81B | | +0.85% | 17.48B | | -21.87% | 15.86B | | +2.32% | 15.35B | | -10.29% | 15.23B | | -22.30% | 13.36B |
Other Specialty Chemicals
|